primary immunodeficiency disease
Information
- Disease name
- primary immunodeficiency disease
- Disease ID
- DOID:612
- Description
- "An immune system disease that results when one or more essential parts of the immune system is missing or not working properly at birth due to a genetic mutation." [url:http\://www.nichd.nih.gov/publications/pubs/primary_immuno.cfm#PrimaryImmunoDiseases]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03961009 | Completed | Phase 3 | Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients | April 30, 2019 | December 21, 2020 |
| NCT01313507 | Completed | Phase 3 | High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam) | May 2011 | September 2012 |
| NCT02810444 | Completed | Phase 3 | Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID | October 4, 2016 | April 1, 2020 |
| NCT04842643 | Completed | Phase 3 | An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease | April 27, 2021 | April 25, 2024 |
| NCT06150833 | Not yet recruiting | Phase 3 | Efficacy and Safety and Pharmacokinetics of Boya IVIG | April 1, 2024 | September 30, 2025 |
| NCT06089122 | Not yet recruiting | Phase 3 | Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIG | April 2024 | June 8, 2025 |
| NCT04944979 | Recruiting | Phase 3 | Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10) | March 31, 2021 | October 30, 2026 |
| NCT03252548 | Unknown status | Pediatric Primary Immunodeficiency Disease (PID) in China | January 2018 | August 2022 | |
| NCT01150240 | Unknown status | Clinical and Laboratory Online Patient- and Research Database for Primary Immunodeficiencies in Switzerland | October 2006 | ||
| NCT03677557 | Unknown status | Phase 4 | Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment | September 19, 2018 | August 31, 2021 |
- Disase is a (Disease Ontology)
- DOID:2914
- Cross Reference ID (Disease Ontology)
- ICD10CM:D84.9
- Cross Reference ID (Disease Ontology)
- ICD9CM:279.3
- Cross Reference ID (Disease Ontology)
- KEGG:05340
- Cross Reference ID (Disease Ontology)
- MESH:D007153
- Cross Reference ID (Disease Ontology)
- MIM:242850
- Cross Reference ID (Disease Ontology)
- MIM:PS300755
- Cross Reference ID (Disease Ontology)
- NCI:C39725
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:191005003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0021051
- Exact Synonym (Disease Ontology)
- hypoimmunity
- Exact Synonym (Disease Ontology)
- immune deficiency disorder
- Exact Synonym (Disease Ontology)
- immunodeficiency syndrome